According to Qatari German Company for Medical Devices's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 69.3912. At the end of 2022 the company had a P/E ratio of 114.
Year | P/E ratio | Change |
---|---|---|
2022 | 114 | -64.07% |
2021 | 318 | 13.57% |
2020 | 280 | -4415.07% |
2019 | -6.49 | 24.18% |
2018 | -5.23 | 52.07% |
2017 | -3.44 | -69.38% |
2016 | -11.2 | -19.78% |
2015 | -14.0 | 60.88% |
2014 | -8.70 | -82.99% |
2013 | -51.1 | 40.03% |
2012 | -36.5 | -114.67% |
2011 | 249 | -843.91% |
2010 | -33.4 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.